Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Henagliflozin proline by Jiangsu Hengrui Medicine for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Henagliflozin proline is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Chronic Kidney Disease (Chronic...